Global Lung Surfactants Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
It is a natural surfactant prepared from the lungs of pigs or cows, which restores breathing through trachea or injection. Mostly used for premature babies.
LPI (LP Information)' newest research report, the “Lung Surfactants Industry Forecast” looks at past sales and reviews total world Lung Surfactants sales in 2022, providing a comprehensive analysis by region and market sector of projected Lung Surfactants sales for 2023 through 2029. With Lung Surfactants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Surfactants industry.
This Insight Report provides a comprehensive analysis of the global Lung Surfactants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lung Surfactants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lung Surfactants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Surfactants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Surfactants.
The global Lung Surfactants market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lung Surfactants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lung Surfactants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lung Surfactants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lung Surfactants players cover Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, Windtree Therapeutics and Aviva Systems Biology Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Surfactants market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Lung Surfactants market?
What factors are driving Lung Surfactants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lung Surfactants market opportunities vary by end market size?
How does Lung Surfactants break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
It is a natural surfactant prepared from the lungs of pigs or cows, which restores breathing through trachea or injection. Mostly used for premature babies.
LPI (LP Information)' newest research report, the “Lung Surfactants Industry Forecast” looks at past sales and reviews total world Lung Surfactants sales in 2022, providing a comprehensive analysis by region and market sector of projected Lung Surfactants sales for 2023 through 2029. With Lung Surfactants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Surfactants industry.
This Insight Report provides a comprehensive analysis of the global Lung Surfactants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lung Surfactants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lung Surfactants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Surfactants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Surfactants.
The global Lung Surfactants market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Lung Surfactants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Lung Surfactants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Lung Surfactants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Lung Surfactants players cover Chiesi Farmaceutici, AbbVie, ONY Biotech, Lyomark Pharma, Windtree Therapeutics and Aviva Systems Biology Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Surfactants market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Intratracheal
- Injectable
- Hospital
- Special Clinic
- Recovery Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chiesi Farmaceutici
- AbbVie
- ONY Biotech
- Lyomark Pharma
- Windtree Therapeutics
- Aviva Systems Biology Corporation
What is the 10-year outlook for the global Lung Surfactants market?
What factors are driving Lung Surfactants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lung Surfactants market opportunities vary by end market size?
How does Lung Surfactants break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Surfactants Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lung Surfactants by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lung Surfactants by Country/Region, 2018, 2022 & 2029
2.2 Lung Surfactants Segment by Type
2.2.1 Intratracheal
2.2.2 Injectable
2.3 Lung Surfactants Sales by Type
2.3.1 Global Lung Surfactants Sales Market Share by Type (2018-2023)
2.3.2 Global Lung Surfactants Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lung Surfactants Sale Price by Type (2018-2023)
2.4 Lung Surfactants Segment by Application
2.4.1 Hospital
2.4.2 Special Clinic
2.4.3 Recovery Center
2.5 Lung Surfactants Sales by Application
2.5.1 Global Lung Surfactants Sale Market Share by Application (2018-2023)
2.5.2 Global Lung Surfactants Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lung Surfactants Sale Price by Application (2018-2023)
3 GLOBAL LUNG SURFACTANTS BY COMPANY
3.1 Global Lung Surfactants Breakdown Data by Company
3.1.1 Global Lung Surfactants Annual Sales by Company (2018-2023)
3.1.2 Global Lung Surfactants Sales Market Share by Company (2018-2023)
3.2 Global Lung Surfactants Annual Revenue by Company (2018-2023)
3.2.1 Global Lung Surfactants Revenue by Company (2018-2023)
3.2.2 Global Lung Surfactants Revenue Market Share by Company (2018-2023)
3.3 Global Lung Surfactants Sale Price by Company
3.4 Key Manufacturers Lung Surfactants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lung Surfactants Product Location Distribution
3.4.2 Players Lung Surfactants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LUNG SURFACTANTS BY GEOGRAPHIC REGION
4.1 World Historic Lung Surfactants Market Size by Geographic Region (2018-2023)
4.1.1 Global Lung Surfactants Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lung Surfactants Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lung Surfactants Market Size by Country/Region (2018-2023)
4.2.1 Global Lung Surfactants Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lung Surfactants Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lung Surfactants Sales Growth
4.4 APAC Lung Surfactants Sales Growth
4.5 Europe Lung Surfactants Sales Growth
4.6 Middle East & Africa Lung Surfactants Sales Growth
5 AMERICAS
5.1 Americas Lung Surfactants Sales by Country
5.1.1 Americas Lung Surfactants Sales by Country (2018-2023)
5.1.2 Americas Lung Surfactants Revenue by Country (2018-2023)
5.2 Americas Lung Surfactants Sales by Type
5.3 Americas Lung Surfactants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Surfactants Sales by Region
6.1.1 APAC Lung Surfactants Sales by Region (2018-2023)
6.1.2 APAC Lung Surfactants Revenue by Region (2018-2023)
6.2 APAC Lung Surfactants Sales by Type
6.3 APAC Lung Surfactants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lung Surfactants by Country
7.1.1 Europe Lung Surfactants Sales by Country (2018-2023)
7.1.2 Europe Lung Surfactants Revenue by Country (2018-2023)
7.2 Europe Lung Surfactants Sales by Type
7.3 Europe Lung Surfactants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Surfactants by Country
8.1.1 Middle East & Africa Lung Surfactants Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lung Surfactants Revenue by Country (2018-2023)
8.2 Middle East & Africa Lung Surfactants Sales by Type
8.3 Middle East & Africa Lung Surfactants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lung Surfactants
10.3 Manufacturing Process Analysis of Lung Surfactants
10.4 Industry Chain Structure of Lung Surfactants
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lung Surfactants Distributors
11.3 Lung Surfactants Customer
12 WORLD FORECAST REVIEW FOR LUNG SURFACTANTS BY GEOGRAPHIC REGION
12.1 Global Lung Surfactants Market Size Forecast by Region
12.1.1 Global Lung Surfactants Forecast by Region (2024-2029)
12.1.2 Global Lung Surfactants Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lung Surfactants Forecast by Type
12.7 Global Lung Surfactants Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Chiesi Farmaceutici
13.1.1 Chiesi Farmaceutici Company Information
13.1.2 Chiesi Farmaceutici Lung Surfactants Product Portfolios and Specifications
13.1.3 Chiesi Farmaceutici Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Chiesi Farmaceutici Main Business Overview
13.1.5 Chiesi Farmaceutici Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Lung Surfactants Product Portfolios and Specifications
13.2.3 AbbVie Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 ONY Biotech
13.3.1 ONY Biotech Company Information
13.3.2 ONY Biotech Lung Surfactants Product Portfolios and Specifications
13.3.3 ONY Biotech Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ONY Biotech Main Business Overview
13.3.5 ONY Biotech Latest Developments
13.4 Lyomark Pharma
13.4.1 Lyomark Pharma Company Information
13.4.2 Lyomark Pharma Lung Surfactants Product Portfolios and Specifications
13.4.3 Lyomark Pharma Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lyomark Pharma Main Business Overview
13.4.5 Lyomark Pharma Latest Developments
13.5 Windtree Therapeutics
13.5.1 Windtree Therapeutics Company Information
13.5.2 Windtree Therapeutics Lung Surfactants Product Portfolios and Specifications
13.5.3 Windtree Therapeutics Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Windtree Therapeutics Main Business Overview
13.5.5 Windtree Therapeutics Latest Developments
13.6 Aviva Systems Biology Corporation
13.6.1 Aviva Systems Biology Corporation Company Information
13.6.2 Aviva Systems Biology Corporation Lung Surfactants Product Portfolios and Specifications
13.6.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aviva Systems Biology Corporation Main Business Overview
13.6.5 Aviva Systems Biology Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Surfactants Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lung Surfactants by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lung Surfactants by Country/Region, 2018, 2022 & 2029
2.2 Lung Surfactants Segment by Type
2.2.1 Intratracheal
2.2.2 Injectable
2.3 Lung Surfactants Sales by Type
2.3.1 Global Lung Surfactants Sales Market Share by Type (2018-2023)
2.3.2 Global Lung Surfactants Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lung Surfactants Sale Price by Type (2018-2023)
2.4 Lung Surfactants Segment by Application
2.4.1 Hospital
2.4.2 Special Clinic
2.4.3 Recovery Center
2.5 Lung Surfactants Sales by Application
2.5.1 Global Lung Surfactants Sale Market Share by Application (2018-2023)
2.5.2 Global Lung Surfactants Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lung Surfactants Sale Price by Application (2018-2023)
3 GLOBAL LUNG SURFACTANTS BY COMPANY
3.1 Global Lung Surfactants Breakdown Data by Company
3.1.1 Global Lung Surfactants Annual Sales by Company (2018-2023)
3.1.2 Global Lung Surfactants Sales Market Share by Company (2018-2023)
3.2 Global Lung Surfactants Annual Revenue by Company (2018-2023)
3.2.1 Global Lung Surfactants Revenue by Company (2018-2023)
3.2.2 Global Lung Surfactants Revenue Market Share by Company (2018-2023)
3.3 Global Lung Surfactants Sale Price by Company
3.4 Key Manufacturers Lung Surfactants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lung Surfactants Product Location Distribution
3.4.2 Players Lung Surfactants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LUNG SURFACTANTS BY GEOGRAPHIC REGION
4.1 World Historic Lung Surfactants Market Size by Geographic Region (2018-2023)
4.1.1 Global Lung Surfactants Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lung Surfactants Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lung Surfactants Market Size by Country/Region (2018-2023)
4.2.1 Global Lung Surfactants Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lung Surfactants Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lung Surfactants Sales Growth
4.4 APAC Lung Surfactants Sales Growth
4.5 Europe Lung Surfactants Sales Growth
4.6 Middle East & Africa Lung Surfactants Sales Growth
5 AMERICAS
5.1 Americas Lung Surfactants Sales by Country
5.1.1 Americas Lung Surfactants Sales by Country (2018-2023)
5.1.2 Americas Lung Surfactants Revenue by Country (2018-2023)
5.2 Americas Lung Surfactants Sales by Type
5.3 Americas Lung Surfactants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Surfactants Sales by Region
6.1.1 APAC Lung Surfactants Sales by Region (2018-2023)
6.1.2 APAC Lung Surfactants Revenue by Region (2018-2023)
6.2 APAC Lung Surfactants Sales by Type
6.3 APAC Lung Surfactants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lung Surfactants by Country
7.1.1 Europe Lung Surfactants Sales by Country (2018-2023)
7.1.2 Europe Lung Surfactants Revenue by Country (2018-2023)
7.2 Europe Lung Surfactants Sales by Type
7.3 Europe Lung Surfactants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Surfactants by Country
8.1.1 Middle East & Africa Lung Surfactants Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lung Surfactants Revenue by Country (2018-2023)
8.2 Middle East & Africa Lung Surfactants Sales by Type
8.3 Middle East & Africa Lung Surfactants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lung Surfactants
10.3 Manufacturing Process Analysis of Lung Surfactants
10.4 Industry Chain Structure of Lung Surfactants
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lung Surfactants Distributors
11.3 Lung Surfactants Customer
12 WORLD FORECAST REVIEW FOR LUNG SURFACTANTS BY GEOGRAPHIC REGION
12.1 Global Lung Surfactants Market Size Forecast by Region
12.1.1 Global Lung Surfactants Forecast by Region (2024-2029)
12.1.2 Global Lung Surfactants Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lung Surfactants Forecast by Type
12.7 Global Lung Surfactants Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Chiesi Farmaceutici
13.1.1 Chiesi Farmaceutici Company Information
13.1.2 Chiesi Farmaceutici Lung Surfactants Product Portfolios and Specifications
13.1.3 Chiesi Farmaceutici Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Chiesi Farmaceutici Main Business Overview
13.1.5 Chiesi Farmaceutici Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Lung Surfactants Product Portfolios and Specifications
13.2.3 AbbVie Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 ONY Biotech
13.3.1 ONY Biotech Company Information
13.3.2 ONY Biotech Lung Surfactants Product Portfolios and Specifications
13.3.3 ONY Biotech Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 ONY Biotech Main Business Overview
13.3.5 ONY Biotech Latest Developments
13.4 Lyomark Pharma
13.4.1 Lyomark Pharma Company Information
13.4.2 Lyomark Pharma Lung Surfactants Product Portfolios and Specifications
13.4.3 Lyomark Pharma Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lyomark Pharma Main Business Overview
13.4.5 Lyomark Pharma Latest Developments
13.5 Windtree Therapeutics
13.5.1 Windtree Therapeutics Company Information
13.5.2 Windtree Therapeutics Lung Surfactants Product Portfolios and Specifications
13.5.3 Windtree Therapeutics Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Windtree Therapeutics Main Business Overview
13.5.5 Windtree Therapeutics Latest Developments
13.6 Aviva Systems Biology Corporation
13.6.1 Aviva Systems Biology Corporation Company Information
13.6.2 Aviva Systems Biology Corporation Lung Surfactants Product Portfolios and Specifications
13.6.3 Aviva Systems Biology Corporation Lung Surfactants Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aviva Systems Biology Corporation Main Business Overview
13.6.5 Aviva Systems Biology Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lung Surfactants Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Lung Surfactants Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intratracheal
Table 4. Major Players of Injectable
Table 5. Global Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 6. Global Lung Surfactants Sales Market Share by Type (2018-2023)
Table 7. Global Lung Surfactants Revenue by Type (2018-2023) & ($ million)
Table 8. Global Lung Surfactants Revenue Market Share by Type (2018-2023)
Table 9. Global Lung Surfactants Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 11. Global Lung Surfactants Sales Market Share by Application (2018-2023)
Table 12. Global Lung Surfactants Revenue by Application (2018-2023)
Table 13. Global Lung Surfactants Revenue Market Share by Application (2018-2023)
Table 14. Global Lung Surfactants Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Lung Surfactants Sales by Company (2018-2023) & (K Units)
Table 16. Global Lung Surfactants Sales Market Share by Company (2018-2023)
Table 17. Global Lung Surfactants Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Lung Surfactants Revenue Market Share by Company (2018-2023)
Table 19. Global Lung Surfactants Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Lung Surfactants Producing Area Distribution and Sales Area
Table 21. Players Lung Surfactants Products Offered
Table 22. Lung Surfactants Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lung Surfactants Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Lung Surfactants Sales Market Share Geographic Region (2018-2023)
Table 27. Global Lung Surfactants Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Lung Surfactants Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Lung Surfactants Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Lung Surfactants Sales Market Share by Country/Region (2018-2023)
Table 31. Global Lung Surfactants Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Lung Surfactants Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Lung Surfactants Sales by Country (2018-2023) & (K Units)
Table 34. Americas Lung Surfactants Sales Market Share by Country (2018-2023)
Table 35. Americas Lung Surfactants Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Lung Surfactants Revenue Market Share by Country (2018-2023)
Table 37. Americas Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 38. Americas Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 39. APAC Lung Surfactants Sales by Region (2018-2023) & (K Units)
Table 40. APAC Lung Surfactants Sales Market Share by Region (2018-2023)
Table 41. APAC Lung Surfactants Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Lung Surfactants Revenue Market Share by Region (2018-2023)
Table 43. APAC Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 44. APAC Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 45. Europe Lung Surfactants Sales by Country (2018-2023) & (K Units)
Table 46. Europe Lung Surfactants Sales Market Share by Country (2018-2023)
Table 47. Europe Lung Surfactants Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Lung Surfactants Revenue Market Share by Country (2018-2023)
Table 49. Europe Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 50. Europe Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Lung Surfactants Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Lung Surfactants Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Lung Surfactants Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Lung Surfactants Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Lung Surfactants
Table 58. Key Market Challenges & Risks of Lung Surfactants
Table 59. Key Industry Trends of Lung Surfactants
Table 60. Lung Surfactants Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Lung Surfactants Distributors List
Table 63. Lung Surfactants Customer List
Table 64. Global Lung Surfactants Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Lung Surfactants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Lung Surfactants Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Lung Surfactants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Lung Surfactants Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Lung Surfactants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Lung Surfactants Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Lung Surfactants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Lung Surfactants Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Lung Surfactants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Lung Surfactants Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Lung Surfactants Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Lung Surfactants Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Lung Surfactants Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Chiesi Farmaceutici Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 79. Chiesi Farmaceutici Lung Surfactants Product Portfolios and Specifications
Table 80. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Chiesi Farmaceutici Main Business
Table 82. Chiesi Farmaceutici Latest Developments
Table 83. AbbVie Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 84. AbbVie Lung Surfactants Product Portfolios and Specifications
Table 85. AbbVie Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. AbbVie Main Business
Table 87. AbbVie Latest Developments
Table 88. ONY Biotech Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 89. ONY Biotech Lung Surfactants Product Portfolios and Specifications
Table 90. ONY Biotech Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. ONY Biotech Main Business
Table 92. ONY Biotech Latest Developments
Table 93. Lyomark Pharma Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 94. Lyomark Pharma Lung Surfactants Product Portfolios and Specifications
Table 95. Lyomark Pharma Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Lyomark Pharma Main Business
Table 97. Lyomark Pharma Latest Developments
Table 98. Windtree Therapeutics Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 99. Windtree Therapeutics Lung Surfactants Product Portfolios and Specifications
Table 100. Windtree Therapeutics Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Windtree Therapeutics Main Business
Table 102. Windtree Therapeutics Latest Developments
Table 103. Aviva Systems Biology Corporation Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 104. Aviva Systems Biology Corporation Lung Surfactants Product Portfolios and Specifications
Table 105. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Aviva Systems Biology Corporation Main Business
Table 107. Aviva Systems Biology Corporation Latest Developments
Table 1. Lung Surfactants Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Lung Surfactants Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Intratracheal
Table 4. Major Players of Injectable
Table 5. Global Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 6. Global Lung Surfactants Sales Market Share by Type (2018-2023)
Table 7. Global Lung Surfactants Revenue by Type (2018-2023) & ($ million)
Table 8. Global Lung Surfactants Revenue Market Share by Type (2018-2023)
Table 9. Global Lung Surfactants Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 11. Global Lung Surfactants Sales Market Share by Application (2018-2023)
Table 12. Global Lung Surfactants Revenue by Application (2018-2023)
Table 13. Global Lung Surfactants Revenue Market Share by Application (2018-2023)
Table 14. Global Lung Surfactants Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Lung Surfactants Sales by Company (2018-2023) & (K Units)
Table 16. Global Lung Surfactants Sales Market Share by Company (2018-2023)
Table 17. Global Lung Surfactants Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Lung Surfactants Revenue Market Share by Company (2018-2023)
Table 19. Global Lung Surfactants Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Lung Surfactants Producing Area Distribution and Sales Area
Table 21. Players Lung Surfactants Products Offered
Table 22. Lung Surfactants Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lung Surfactants Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Lung Surfactants Sales Market Share Geographic Region (2018-2023)
Table 27. Global Lung Surfactants Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Lung Surfactants Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Lung Surfactants Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Lung Surfactants Sales Market Share by Country/Region (2018-2023)
Table 31. Global Lung Surfactants Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Lung Surfactants Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Lung Surfactants Sales by Country (2018-2023) & (K Units)
Table 34. Americas Lung Surfactants Sales Market Share by Country (2018-2023)
Table 35. Americas Lung Surfactants Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Lung Surfactants Revenue Market Share by Country (2018-2023)
Table 37. Americas Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 38. Americas Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 39. APAC Lung Surfactants Sales by Region (2018-2023) & (K Units)
Table 40. APAC Lung Surfactants Sales Market Share by Region (2018-2023)
Table 41. APAC Lung Surfactants Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Lung Surfactants Revenue Market Share by Region (2018-2023)
Table 43. APAC Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 44. APAC Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 45. Europe Lung Surfactants Sales by Country (2018-2023) & (K Units)
Table 46. Europe Lung Surfactants Sales Market Share by Country (2018-2023)
Table 47. Europe Lung Surfactants Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Lung Surfactants Revenue Market Share by Country (2018-2023)
Table 49. Europe Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 50. Europe Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Lung Surfactants Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Lung Surfactants Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Lung Surfactants Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Lung Surfactants Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Lung Surfactants Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Lung Surfactants Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Lung Surfactants
Table 58. Key Market Challenges & Risks of Lung Surfactants
Table 59. Key Industry Trends of Lung Surfactants
Table 60. Lung Surfactants Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Lung Surfactants Distributors List
Table 63. Lung Surfactants Customer List
Table 64. Global Lung Surfactants Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Lung Surfactants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Lung Surfactants Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Lung Surfactants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Lung Surfactants Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Lung Surfactants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Lung Surfactants Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Lung Surfactants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Lung Surfactants Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Lung Surfactants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Lung Surfactants Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Lung Surfactants Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Lung Surfactants Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Lung Surfactants Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Chiesi Farmaceutici Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 79. Chiesi Farmaceutici Lung Surfactants Product Portfolios and Specifications
Table 80. Chiesi Farmaceutici Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Chiesi Farmaceutici Main Business
Table 82. Chiesi Farmaceutici Latest Developments
Table 83. AbbVie Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 84. AbbVie Lung Surfactants Product Portfolios and Specifications
Table 85. AbbVie Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. AbbVie Main Business
Table 87. AbbVie Latest Developments
Table 88. ONY Biotech Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 89. ONY Biotech Lung Surfactants Product Portfolios and Specifications
Table 90. ONY Biotech Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. ONY Biotech Main Business
Table 92. ONY Biotech Latest Developments
Table 93. Lyomark Pharma Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 94. Lyomark Pharma Lung Surfactants Product Portfolios and Specifications
Table 95. Lyomark Pharma Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Lyomark Pharma Main Business
Table 97. Lyomark Pharma Latest Developments
Table 98. Windtree Therapeutics Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 99. Windtree Therapeutics Lung Surfactants Product Portfolios and Specifications
Table 100. Windtree Therapeutics Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Windtree Therapeutics Main Business
Table 102. Windtree Therapeutics Latest Developments
Table 103. Aviva Systems Biology Corporation Basic Information, Lung Surfactants Manufacturing Base, Sales Area and Its Competitors
Table 104. Aviva Systems Biology Corporation Lung Surfactants Product Portfolios and Specifications
Table 105. Aviva Systems Biology Corporation Lung Surfactants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Aviva Systems Biology Corporation Main Business
Table 107. Aviva Systems Biology Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Lung Surfactants
Figure 2. Lung Surfactants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lung Surfactants Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Lung Surfactants Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Lung Surfactants Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intratracheal
Figure 10. Product Picture of Injectable
Figure 11. Global Lung Surfactants Sales Market Share by Type in 2022
Figure 12. Global Lung Surfactants Revenue Market Share by Type (2018-2023)
Figure 13. Lung Surfactants Consumed in Hospital
Figure 14. Global Lung Surfactants Market: Hospital (2018-2023) & (K Units)
Figure 15. Lung Surfactants Consumed in Special Clinic
Figure 16. Global Lung Surfactants Market: Special Clinic (2018-2023) & (K Units)
Figure 17. Lung Surfactants Consumed in Recovery Center
Figure 18. Global Lung Surfactants Market: Recovery Center (2018-2023) & (K Units)
Figure 19. Global Lung Surfactants Sales Market Share by Application (2022)
Figure 20. Global Lung Surfactants Revenue Market Share by Application in 2022
Figure 21. Lung Surfactants Sales Market by Company in 2022 (K Units)
Figure 22. Global Lung Surfactants Sales Market Share by Company in 2022
Figure 23. Lung Surfactants Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Lung Surfactants Revenue Market Share by Company in 2022
Figure 25. Global Lung Surfactants Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Lung Surfactants Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Lung Surfactants Sales 2018-2023 (K Units)
Figure 28. Americas Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 29. APAC Lung Surfactants Sales 2018-2023 (K Units)
Figure 30. APAC Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 31. Europe Lung Surfactants Sales 2018-2023 (K Units)
Figure 32. Europe Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Lung Surfactants Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 35. Americas Lung Surfactants Sales Market Share by Country in 2022
Figure 36. Americas Lung Surfactants Revenue Market Share by Country in 2022
Figure 37. Americas Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 38. Americas Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 39. United States Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Lung Surfactants Sales Market Share by Region in 2022
Figure 44. APAC Lung Surfactants Revenue Market Share by Regions in 2022
Figure 45. APAC Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 46. APAC Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 47. China Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Lung Surfactants Sales Market Share by Country in 2022
Figure 55. Europe Lung Surfactants Revenue Market Share by Country in 2022
Figure 56. Europe Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 57. Europe Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 58. Germany Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Lung Surfactants Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Lung Surfactants Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 67. Egypt Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Lung Surfactants in 2022
Figure 73. Manufacturing Process Analysis of Lung Surfactants
Figure 74. Industry Chain Structure of Lung Surfactants
Figure 75. Channels of Distribution
Figure 76. Global Lung Surfactants Sales Market Forecast by Region (2024-2029)
Figure 77. Global Lung Surfactants Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Lung Surfactants Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Lung Surfactants Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Lung Surfactants Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Lung Surfactants Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Lung Surfactants
Figure 2. Lung Surfactants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lung Surfactants Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Lung Surfactants Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Lung Surfactants Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Intratracheal
Figure 10. Product Picture of Injectable
Figure 11. Global Lung Surfactants Sales Market Share by Type in 2022
Figure 12. Global Lung Surfactants Revenue Market Share by Type (2018-2023)
Figure 13. Lung Surfactants Consumed in Hospital
Figure 14. Global Lung Surfactants Market: Hospital (2018-2023) & (K Units)
Figure 15. Lung Surfactants Consumed in Special Clinic
Figure 16. Global Lung Surfactants Market: Special Clinic (2018-2023) & (K Units)
Figure 17. Lung Surfactants Consumed in Recovery Center
Figure 18. Global Lung Surfactants Market: Recovery Center (2018-2023) & (K Units)
Figure 19. Global Lung Surfactants Sales Market Share by Application (2022)
Figure 20. Global Lung Surfactants Revenue Market Share by Application in 2022
Figure 21. Lung Surfactants Sales Market by Company in 2022 (K Units)
Figure 22. Global Lung Surfactants Sales Market Share by Company in 2022
Figure 23. Lung Surfactants Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Lung Surfactants Revenue Market Share by Company in 2022
Figure 25. Global Lung Surfactants Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Lung Surfactants Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Lung Surfactants Sales 2018-2023 (K Units)
Figure 28. Americas Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 29. APAC Lung Surfactants Sales 2018-2023 (K Units)
Figure 30. APAC Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 31. Europe Lung Surfactants Sales 2018-2023 (K Units)
Figure 32. Europe Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Lung Surfactants Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Lung Surfactants Revenue 2018-2023 ($ Millions)
Figure 35. Americas Lung Surfactants Sales Market Share by Country in 2022
Figure 36. Americas Lung Surfactants Revenue Market Share by Country in 2022
Figure 37. Americas Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 38. Americas Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 39. United States Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Lung Surfactants Sales Market Share by Region in 2022
Figure 44. APAC Lung Surfactants Revenue Market Share by Regions in 2022
Figure 45. APAC Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 46. APAC Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 47. China Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Lung Surfactants Sales Market Share by Country in 2022
Figure 55. Europe Lung Surfactants Revenue Market Share by Country in 2022
Figure 56. Europe Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 57. Europe Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 58. Germany Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Lung Surfactants Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Lung Surfactants Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Lung Surfactants Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Lung Surfactants Sales Market Share by Application (2018-2023)
Figure 67. Egypt Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Lung Surfactants Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Lung Surfactants in 2022
Figure 73. Manufacturing Process Analysis of Lung Surfactants
Figure 74. Industry Chain Structure of Lung Surfactants
Figure 75. Channels of Distribution
Figure 76. Global Lung Surfactants Sales Market Forecast by Region (2024-2029)
Figure 77. Global Lung Surfactants Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Lung Surfactants Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Lung Surfactants Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Lung Surfactants Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Lung Surfactants Revenue Market Share Forecast by Application (2024-2029)
